B+
Bull case
20%
Probability
Target price
$31.00
Analysis reference price unavailable
Analysis 2026-05-20 · RankAlpha Sentiment Codex
CTEV
ClaritevFNYSE / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
Q1 showed continued revenue growth and solid adjusted EBITDA, while PHCS Novera gives Claritev a tangible 2026 product-rollout path. If management can keep growth moving and convert the launch into commercial wins while holding covenant compliance and improving cash flow, the equity can rerate from a depressed leverage discount.
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.3.
What can break
Gross debt remains high at roughly $4.6 billion, so interest burden and refinancing sensitivity still matter.
Momentum
6
Value
51
Sentiment
38
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $20.50 · Bull $31.00 · Bear $9.50Analysis 2026-05-20; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-20 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-23
Investment thesis
As of 2026-10-23
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $46.00
Why
Momentum6 · Δ7d +1.7
Value51 · Δ7d +0.3
Sentiment38 · Δ7d -4.6
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Value remains the lead driver in the composite, 7D delta +0.3.
Contradictions & invalidation
- • Gross debt remains high at roughly $4.6 billion, so interest burden and refinancing sensitivity still matter.
- • If operating momentum stalls, leverage can keep the equity in a low-multiple state even with revenue growth.
- • The countercase is that Claritev still carries very heavy debt, modest cash, and a meaningful net loss.
Catalyst clock
2026-05-20
Q1 2026 print still anchors near-term trading
Lead driver: Value · See fundamentals
Momentum
6
8% active weight
Current posture
7d trendFlat
Δ7d
+1.7
Δ21d
+2.7
Value
51
47% active weight
Current posture
7d trendFlat
Δ7d
+0.3
Δ21d
+0.2
Sentiment
38
45% active weight
Current posture
7d trendSoftening
Δ7d
-4.6
Δ21d
-5.5
Why this grade
Composite grade F. Momentum 5.8 / Value 51.2 / Sentiment 38.0
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-05-20. Scenario method
Most likely
B
Base case
55%
Probability
Target price
$20.50
Analysis reference price unavailable
Analysis 2026-05-20 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$9.50
Analysis reference price unavailable
Analysis 2026-05-20 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-23
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$398.27M
Beta
0.53
Shares Out
16.95M
P/E (TTM) · Derived
-1.4
P/S (TTM)
0.51
P/FCF (TTM) · Derived
-21.04
Rev YoY
+6.6%
EPS YoY
-8.3%
Gross Margin
+28.2%
Op Margin
+4.2%
Net Debt
$4.59B
Current Ratio
1.00
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data